Actavis Laboratories FL, Inc. v. US

  1. June 07, 2024

    Fed. Circ. Panel Doubts Bid To Nix Actavis' $12M Deduction

    A Federal Circuit panel seemed skeptical of the government's bid to overturn a decision allowing drugmaker Actavis to deduct $12 million it spent fending off lawsuits as it secured approval to sell generics, raising the question during oral arguments Friday whether the company was being uniquely targeted.

  2. March 21, 2023

    Fed. Circ. Urged To Upend Actavis' $12M Legal Fee Deduction

    The Federal Circuit should reverse a decision allowing drugmaker Actavis to deduct as regular business expenses $12 million it spent fighting lawsuits as it tried to secure approval to sell generic birth control and other drugs, the government argued.